The focus of this proposal is to determine the roles the recently described prolactin releasing peptides (PrRPs) may play in stress-induced elevations of prolactin secretion (neuroendocrine actions in pituitary gland and neuromodulatory actions in brain) and autonomic function (neuromodulator actions in brain). We hypothesize that the PrRPs produced in brain and pituitary gland are required for the normal neuroendocrine and cardiovascular responses to stress. Specifically we hypothesize that PrRPs, either produced locally in pituitary gland or delivered to the gland via either the portal or peripheral circulations, play a role in the secretion of prolactin from the gland during stress. Furthermore, we hypothesize that the elevation in sympathetic tone during stress depends upon the actions of brain-derived PrRPs and that removal of those peptides will compromise the animal's cardiovascular response to stress. We will address the following Specific Aims (Questions): 1) Will physical or anticipatory stress elevate circulating plasma levels of PrRP, tissue levels of the peptides (brain, pituitary, adrenal), or expression of the gene (mRNA levels) in brain, pituitary gland or adrenal medulla? 2) Are the PrRPs effective releasing factors in the setting of dopamine withdrawal (which occurs in stress)? 3) Will central administration of PrRP stimulate prolactin secretion in conscious animals? 4) Can the site of action of PrRP in brain be identified by site-specific injections? 5) Will compromise of endogenous PrRP alter the neuroendocrine and cardiovascular responses to stress? The studies described here are designed to further characterize the pharmacology and physiology of the PrRPs, which have been demonstrated to act in the pituitary as neuroendocrine factors and in brain as modulators of autonomic outflow. The ultimate goal is to determine their importance in the maintenance of normal endocrine and cardiovascular function, in particular during stress. These studies will also begin to examine a potentially novel confluence of endocrine and autonomic responses to stress and thereby provide insight into the coordinated responses of multiple organ systems to stress.
| Samson, Willis K; Stein, Lauren M; Elrick, Mollisa et al. (2016) Hypoglycemia unawareness prevention: Targeting glucagon production. Physiol Behav 162:147-50 |
| Yosten, Gina L C; Liu, Jun; Ji, Hong et al. (2016) A 5'-upstream short open reading frame encoded peptide regulates angiotensin type 1a receptor production and signalling via the ?-arrestin pathway. J Physiol 594:1601-5 |
| Yosten, Gina L C; Elrick, Mollisa M; Salvatori, Alison et al. (2015) Understanding peptide biology: The discovery and characterization of the novel hormone, neuronostatin. Peptides 72:192-5 |
| Yosten, Gina L C; Samson, Willis K (2014) Neural circuitry underlying the central hypertensive action of nesfatin-1: melanocortins, corticotropin-releasing hormone, and oxytocin. Am J Physiol Regul Integr Comp Physiol 306:R722-7 |
| Liu, Jun; Yosten, Gina L C; Ji, Hong et al. (2014) Selective inhibition of angiotensin receptor signaling through Erk1/2 pathway by a novel peptide. Am J Physiol Regul Integr Comp Physiol 306:R619-26 |
| Pate, Alicia T; Yosten, Gina L C; Samson, Willis K (2013) Neuropeptide W increases mean arterial pressure as a result of behavioral arousal. Am J Physiol Regul Integr Comp Physiol 305:R804-10 |
| Yosten, Gina L C; Kolar, Grant R; Redlinger, Lauren J et al. (2013) Evidence for an interaction between proinsulin C-peptide and GPR146. J Endocrinol 218:B1-8 |
| Sandberg, Kathryn; Samson, Willis K; Ji, Hong (2013) Decoding noncoding RNA: da Vinci redux? Circ Res 113:240-1 |
| Yosten, Gina L C; Kolar, Grant R; Redlinger, Lauren J et al. (2013) Evidence for an interaction between proinsulin C-peptide and GPR146. J Endocrinol 218:B1-8 |
| Yosten, G L C; Lyu, R-M; Hsueh, A J W et al. (2013) A novel reproductive peptide, phoenixin. J Neuroendocrinol 25:206-15 |
Showing the most recent 10 out of 34 publications
